Novel anti-angiogenic therapies for malignant gliomas
Author:
Publisher
Elsevier BV
Subject
Clinical Neurology
Reference84 articles.
1. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma;Stupp;N Engl J Med,2005
2. Highly anaplastic astrocytoma: a review of 357 patients treated between 1977 and 1989;Prados;Int J Radiat Oncol BiolPhys,1992
3. Phase III randomized study of radiotherapy plus procarbazine, lomustine, and vincristine with or without BUdR for treatment of anaplastic astrocytoma: final report of RTOG 9404;Prados;Int J Radiat Oncol BiolPhys,2004
4. Adjuvant Procarbazine, Lomustine, and Vincristine Improves Progression-Free Survival but Not Overall Survival in Newly Diagnosed Anaplastic Oligodendrogliomas and Oligoastrocytomas: A Randomized European Organisation for Research and Treatment of Cancer Phase III Trial
5. A phase II study of temozolomide vs. procarbazine in patients with glioblastoma multiforme at first relapse;Yung;Br J Cancer,2000
Cited by 195 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. The immunological landscape of peripheral blood in glioblastoma patients and immunological consequences of age and dexamethasone treatment;Frontiers in Immunology;2024-01-18
2. Updated Response Assessment in Neuro-Oncology (RANO) for Gliomas;Current Neurology and Neuroscience Reports;2024-01-03
3. Preclinical and early clinical studies of a novel compound SYHA1813 that efficiently crosses the blood–brain barrier and exhibits potent activity against glioblastoma;Acta Pharmaceutica Sinica B;2023-12
4. Discovery of a Dual Tubulin and Neuropilin-1 (NRP1) Inhibitor with Potent In Vivo Anti-Tumor Activity via Pharmacophore-based Docking Screening, Structure Optimization, and Biological Evaluation;Journal of Medicinal Chemistry;2023-11-24
5. The origin of brain malignancies at the blood–brain barrier;Cellular and Molecular Life Sciences;2023-09-09
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3